← SynDRA
NALOXONE BENZOYLHYDRAZONE
SynDRA canonical compound SYN0024706 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | OPRM1 |
|---|
| Mechanism of action | Opioid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Opioid receptor antagonist
- OPRK1 PARTIAL AGONIST
- OPRM1 ANTAGONIST
- OPRK1 INHIBITOR
- OPRM1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- APEX1
- ARSA
- ATXN2
- BLM
- CYP3A4
- EHMT2
- GLS
- GMNN
- HDAC6
- KCNH2
- LMNA
- RGS4
- USP1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- NalBzOH
- 6-Desoxy-6-benzoylhydrazido-N-allyl-14-hydroxydihydronormorphinone
- Benzoic acid, ((5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene)hydrazide
- Lopac0_000882
- [(5alpha)-4,5-Epoxy-
- MLS000860072
- Naloxone benzoylhydrazone, solid
- SCHEMBL15423902
- CHEMBL1256836
- MolPort-003-958-927
- MFCD05662358
- AKOS024456586
- CCG-204964
- NCGC00092281-03
- NCGC00092281-02
- NCGC00092281-04
- NCGC00092281-01
- SMR000326930
- N-165
- EU-0100882
- SR-01000075513
- SR-01000075513-1
- Nalbzoh
- 0W13ZI072Q
- RefChem:164463
- DTXCID701476378
- UNII-0W13ZI072Q
- GTPL1664
- HMS3412O16
- HMS3676O16
- SDCCGSBI-0050857.P002
- DA-55990
- MS-32821
- HY-107743
- CS-0029440
- BRD-K70898774-001-03-5
Look up NALOXONE BENZOYLHYDRAZONE in the interactive SynDRA portal →